Holen Sie sich die Stockscreener-App
23.39
2.26%
-0.54
Schlusskurs vom Vortag:
$23.93
Offen:
$24.03
24-Stunden-Volumen:
936.06K
Relative Volume:
0.29
Marktkapitalisierung:
$1.46B
Einnahmen:
$14.34M
Nettoeinkommen (Verlust:
$-199.00M
KGV:
-5.9668
EPS:
-3.92
Netto-Cashflow:
$-183.51M
1W Leistung:
-5.72%
1M Leistung:
-7.62%
6M Leistung:
+63.80%
1J Leistung:
+29.58%
1-Tages-Spanne:
$23.14
$24.10
1-Wochen-Bereich:
$23.14
$24.80
52-Wochen-Spanne:
$7.76
$71.50
Uniqure N V Stock (QURE) Company Profile
Firmenname
Uniqure N V
Sektor
Branche
Telefon
1-339-970-7000
Adresse
PAASHEUVELWEG 25A, AMSTERDAM
Vergleichen Sie QURE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
QURE
Uniqure N V
|
23.39 | 1.49B | 14.34M | -199.00M | -183.51M | -3.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.13 | 115.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.31 | 81.12B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
400.17 | 52.54B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
839.99 | 51.78B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
177.12 | 37.12B | 447.02M | -1.18B | -906.14M | -6.1812 |
Uniqure N V Stock (QURE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-04 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2025-08-14 | Hochstufung | Mizuho | Neutral → Outperform |
| 2025-04-01 | Fortgesetzt | Chardan Capital Markets | Buy |
| 2024-12-10 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2024-10-10 | Fortgesetzt | Raymond James | Outperform |
| 2024-02-29 | Herabstufung | Goldman | Buy → Neutral |
| 2023-12-19 | Herabstufung | Mizuho | Buy → Neutral |
| 2022-03-17 | Hochstufung | UBS | Neutral → Buy |
| 2021-06-15 | Eingeleitet | BTIG Research | Buy |
| 2021-05-21 | Eingeleitet | UBS | Neutral |
| 2021-04-26 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-04-01 | Hochstufung | Mizuho | Neutral → Buy |
| 2021-01-07 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-11-24 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-11-11 | Eingeleitet | Berenberg | Buy |
| 2020-11-09 | Eingeleitet | Jefferies | Buy |
| 2020-11-04 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-10-23 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2020-08-25 | Eingeleitet | Raymond James | Strong Buy |
| 2020-07-31 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-06-25 | Herabstufung | Mizuho | Buy → Neutral |
| 2020-06-25 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-06-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2019-12-03 | Eingeleitet | Cowen | Outperform |
| 2019-12-03 | Eingeleitet | Goldman | Buy |
| 2019-11-05 | Eingeleitet | Credit Suisse | Outperform |
| 2019-10-11 | Eingeleitet | Stifel | Buy |
| 2019-09-25 | Eingeleitet | Bernstein | Outperform |
| 2019-09-12 | Eingeleitet | Mizuho | Buy |
| 2019-07-30 | Herabstufung | Guggenheim | Buy → Neutral |
| 2019-07-08 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2019-04-12 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-03-29 | Eingeleitet | Robert W. Baird | Outperform |
Alle ansehen
Uniqure N V Aktie (QURE) Neueste Nachrichten
uniQure (NASDAQ:QURE) Upgraded at Wall Street Zen - MarketBeat
How reliable is uniQure NV UQ1 stock dividend growth2025 Big Picture & Technical Pattern Based Buy Signals - moha.gov.vn
QURE Investigation Reminder: Kessler Topaz Meltzer & Check, - GlobeNewswire
QURE Investigation Notice: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm - PR Newswire
QURE INVESTIGATION REMINDER: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors With Significant Losses to Contact the Firm - NewMediaWire
Whittier Daily News - FinancialContent
Understanding Momentum Shifts in (QURE) - Stock Traders Daily
uniQure N.V. (NASDAQ:QURE) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
uniQure (NASDAQ:QURE) Trading 5.4% HigherWhat's Next? - MarketBeat
Gene therapy genie back in the bottle? - BioWorld MedTech
uniQure Notice of Investigation: Kessler Topaz Meltzer & - GlobeNewswire
QURE Investigation: Kessler Topaz Meltzer & Check, LLP Encourage - GuruFocus
QURE Investigation: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm - PR Newswire
uniQure (NASDAQ:QURE) Trading Down 4.6%Here's Why - MarketBeat
Cell And Gene Therapy Leaders See Transformative Results Outweighing Industry Setbacks - Citeline News & Insights
What do analysts think about UniQure (QURE)? - MSN
What Do Analysts Think About UniQure (QURE)? - Finviz
How uniQure N.V. stock benefits from tech adoptionJuly 2025 Closing Moves & Fast Moving Stock Watchlists - Улправда
Quarterly Earnings: How uniQure N.V. stock benefits from tech adoptionJuly 2025 Setups & Reliable Breakout Forecasts - Улправда
Is uniQure N.V. stock positioned for long term growthLong Setup & Growth-Oriented Investment Plans - ulpravda.ru
What hedge fund moves indicate for uniQure N.V. (UQ1) stockJuly 2025 Breakouts & AI Powered Buy/Sell Recommendations - Улправда
How sustainable is uniQure N.V. stock dividend payoutJuly 2025 Trends & Weekly Watchlist for Consistent Profits - ulpravda.ru
Revisiting UniQure (NASDAQ:QURE) - Seeking Alpha
uniQure: Why Waiting For Clarity Beats Chasing The Next Step Jump (NASDAQ:QURE) - Seeking Alpha
uniQure (NASDAQ:QURE) Shares Up 14%What's Next? - MarketBeat
Sanders Morris Harris LLC Makes New $5.08 Million Investment in uniQure N.V. $QURE - MarketBeat
Revenue per share of uniQure N.V. – LSX:A1XDTV - TradingView — Track All Markets
What's Going On With uniQure Stock On Tuesday? - Benzinga
uniQure (NASDAQ:QURE) Shares Gap UpWhat's Next? - MarketBeat
uniQure (QURE) Stock Jumps in Pre-Market on Dec. 16, 2025: FDA AMT-130 Uncertainty, Analyst Price Targets, and Key Catalysts Ahead - ts2.tech
UniQure (QURE) Stock Drop Looms as FDA Concern Over Huntington's Data Spurs Mizuho Downgrade and Delayed Launch - Finviz
UniQure (QURE) Stock Drop Looms as FDA Concern Over Huntington’s Data Spurs Mizuho Downgrade and Delayed Launch - Insider Monkey
(QURE) as a Liquidity Pulse for Institutional Tactics - news.stocktradersdaily.com
Wall Street Has a Positive Outlook on uniQure N.V. (QURE) Despite Challenges From The FDA - MSN
QURE INVESTIGATION: Kessler Topaz Meltzer & Check, LLP - GlobeNewswire
QURE Investigation: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors With Significant Losses to Contact the Firm - NewMediaWire
Stifel Maintains uniQure N.V. (QURE) Buy Recommendation - Nasdaq
QURE Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors With Significant Losses to Contact the Firm - NewMediaWire
uniQure (NASDAQ:QURE) Price Target Lowered to $40.00 at Stifel Nicolaus - MarketBeat
Roku To Rally More Than 28%? Here Are 10 Top Analyst Forecasts For Thursday - Benzinga
uniQure (QURE) Price Target Lowered by Stifel Analyst | QURE Sto - GuruFocus
QURE Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm - Prime Publishers, Inc.
Stempoint Capital LP Has $7.98 Million Stock Holdings in uniQure N.V. $QURE - MarketBeat
Mizuho Maintains uniQure N.V. (QURE) Outperform Recommendation - Nasdaq
Mizuho Lowers Price Target for uniQure (QURE) to $33.00 | QURE S - GuruFocus
Mizuho Securities Maintains UniQure NV(QURE.US) With Buy Rating, Maintains Target Price $33 - 富途牛牛
Swiss National Bank Makes New Investment in uniQure N.V. $QURE - MarketBeat
Mizuho Securities Maintains UniQure NV(QURE.US) With Buy Rating, Cuts Target Price to $33 - 富途牛牛
uniQure NV (HAM:UQ1) Non Operating Income : €-3.54 Mil (TTM As of Sep. 2025) - GuruFocus
uniQure NV (HAM:UQ1) Asset Impairment Charge : €0.00 Mil (TTM As of Sep. 2025) - GuruFocus
uniQure NV (HAM:UQ1) Total Long-Term Liabilities : €476.27 Mil (As of Sep. 2025) - GuruFocus
Finanzdaten der Uniqure N V-Aktie (QURE)
Umsatz
Nettogewinn
Free Cashflow
ENV
Uniqure N V-Aktie (QURE) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Gut Robert | Director |
Nov 06 '25 |
Sale |
27.26 |
31,434 |
856,881 |
40,145 |
| Kaye Jack | Director |
Nov 04 '25 |
Option Exercise |
9.88 |
38,810 |
383,535 |
38,249 |
| Kaye Jack | Director |
Nov 04 '25 |
Sale |
30.34 |
38,810 |
1,177,517 |
20,439 |
0.57%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):